Author:
Sagnia Bertrand,Kiazyk Sandra,Meyers Adrienne F. A.,Plews Margot,Diallo Tamsir O.,Sosso Samuel Martin,Ambada Georgia,Kamgaing Rachel,Nji Nadesh,Sandstrom Paul,Ball Blake T.,Nchinda Godwin,Ndjolo Alexis
Abstract
AbstractParticipation in an EQA program is critical to the quality assurance process. Reliable and precise CD4 T-cells enumeration are essential to improve the clinical management of patients by evaluating the disease progression and by monitoring the effectiveness of ART in HIV-patients. The CIRCB, CD4 reference laboratory, in collaboration with the Canadian QASI-program, recruited sites, distributed and analyzed CD4-panels in 61 sites across Cameroon. A trend and performance analysis in the pre-analytical, analytical and post-analytical phases was performed. Continuous training and corrective actions carried out from 2014 to 2018 increased the number of participating sites from 15 to 61 sites, the number of unacceptable results decreased from 50 to 10%. Specific challenges included errors in pre analytic (17.5%), analytic (77.0%) and post-analytic (5.5%) phases. This EQA requires the application of good laboratory practices, fluidic communication between all the stakeholders, continuous training, application of specific on-site corrective measures, and timely equipment maintenance in order to avoid repetitive errors and to increase laboratory performance. It could be extended to other HIV-1 testing like viral load and EID point-of-care. Partnership with QASI serve as a model for implementation of a successful EQA model for resource limited countries wanting to implement EQA for HIV testing and monitoring in alignment with 90–90–90 targets.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. UNAIDS. UNAIDS Data 2019 [Internet]. UNAIDS; https://www.unaidsorg/en/resources/documents/2019/2019-UNAIDS-data (2019).
2. UNAIDS. 90–90–90 An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2014).
3. Organization, W. H. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Worl Health Org. 12, 1361–1364 (2016).
4. Ford, N. et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect. Dis 15(2), 241–247 (2015).
5. Peter, T. et al. Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing. J. Int. AIDS Soc. 20(Suppl 7), e25008 (2017).